BioRestorative Therapies Announces New Initiative to Target Polycystic Ovarian Syndrome

    NEXT STORY
    T2 Biosystems Receives Funding from BARDA to Advance Technology for Diagnosis and Treatment of Bloodstream Infections
    PREV STORY
    Athenex Announces Initiation of Phase I Clinical Study in China of KX2-361 Oral by Partner Guangzhou Xiangxue Pharmaceutical
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Dr. Demetre Daskalakis to Receive Esperanza (Hope) Award at Cielo Gala 2016

    NEW YORK, April 20, 2016 (GLOBE NEWSWIRE) -- Dr. Demetre Daskalakis, Assistant Commissioner of ...

    author_avatar
    NASDAQ Market News

    NanoString Highlights Advances in Product Pipeline and Application Development at the 2018 Association of Molecular Pathology Conference

    Demonstrates Potential of Hyb & Seq NGS Platform for Infectious Disease Applications SEATTLE, Oct. ...

    author_avatar
    NASDAQ Market News

    Arcturus Therapeutics to Present at October Investor Conferences

    SAN DIEGO, Sept. 25, 2018 (GLOBE NEWSWIRE) -- Arcturus Therapeutics Ltd. (NASDAQ: ARCT), a ...

    author_avatar
    NASDAQ Market News